Willoughby, Jennifer L. S.
George, Kelly
Roberto, Mark P.
Chin, Hang Gyeong
Stoiber, Patrick
Shin, Hyunjin
Pedamallu, Chandra Sekhar
Schaus, Scott E.
Fitzgerald, Kevin
Shah, Jagesh
Hansen, Ulla https://orcid.org/0000-0001-9803-4185
Funding for this research was provided by:
Alnylam Pharmaceuticals (NA, NA)
Boston University (NA, NA, NA)
Boston University Undergraduate Research Opportunity (NA)
New England Biolabs (NA)
National Institutes of Health (R01 GM078240)
Article History
Received: 11 February 2020
Accepted: 4 June 2020
First Online: 6 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: SES and UH are co-founders of Lamerigen, Inc. JLSW and KF are employed by Alnylam Pharmaceuticals. The remaining authors declare no potential conflict of interest.